Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q09472 (EP300_HUMAN) Homo sapiens (Human)

Histone acetyltransferase p300 UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

2414 aa; Sequence (Fasta)

Available Structures

56 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of p300-p53 protein complex Heteromer
P04637;
1046-1664
Assess
Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 2 (4.8 ang… Heteromer
P04908; P06899; P62805; P68431;
1050-1664
Assess
Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 1 (4.7 ang… Heteromer
P04908; P06899; P62805; P68431;
1051-1664
Assess
Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 1 (3.2 ang… Heteromer
P04908; P06899; P62805; P68431;
1051-1664
Assess
Cryo-EM structure of nucleosome in complex with p300 acetyltransferase catalytic core (complex I) Heteromer
P04908; P06899; P62805; P68431;
1048-1661
Assess
Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 4 (4.5 ang… Heteromer
P04908; P06899; P62805; P68431;
1051-1664
Assess
Cryo-EM structure of the p300 catalytic core bound to the H4K12acK16ac nucleosome, class 2 (3.9 ang… Heteromer
P04908; P06899; P62805; P68431;
1054-1664
Assess
Transcription factor dimerization activates the p300 acetyltransferase Heteromer
P62799;
1047-1168
ZN;
Assess
Crystal structure of the p300 TAZ2 domain bound to MEF2 on DNA Heteromer
Q02078;
1726-1835
ZN;
Assess
Solution structure of the CITED2 transactivation domain in complex with the p300 CH1 domain Heteromer
Q99967;
323-423
ZN;
Assess
NMR Structures of the HIF-1alpha CTAD/p300 CH1 Complex Heteromer
Q16665;
323-423
ZN;
Assess
Crystal structure of p300 CH1 domain in complex with CITIF (a CITED2-HIF-1alpha hybrid) Heteromer
Q16665; Q99967;
330-420
ZN;
Assess
Solution NMR structure of the p300 Taz2:ETAD1 complex Heteromer
P15923;
1723-1812
Assess
NMR-derived ensemble of the TAZ2 domain of p300 bound to the microphthalmia-associated transcriptio… Heteromer
O75030;
1723-1812
ZN;
Assess
Structural Basis for the Regulation of p53 Function by p300 Heteromer
P04637;
1723-1812
Assess
Characterization of the p300 Taz2-p53 TAD2 Complex and Comparison with the p300 Taz2-p53 TAD1 Compl… Heteromer
P04637;
1723-1812
Assess
NMR solution structures of p300 TAZ2 domain in complex with BRD4-NUT F1c domain binding motif #1 Heteromer
Q86Y26;
1723-1812
ZN;
Assess
Structural basis for autoinhibition of the acetyltransferase activity of p300homo-2-mer1046-1664
ZN;01K;
Assess
Transcription factor dimerization activates the p300 acetyltransferasehomo-2-mer1046-1664
ZN;01K;
Assess
Crystal structure of p300 ZZ domain in complex with histone H3 peptidehomo-2-mer1661-1709
ZN;CL;
Assess
Cryo-EM structure of p300monomer1046-1664
Assess
Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme A.monomer1046-1662
ZN;BCO;GOL;DMS;CL;
Assess
Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme A.monomer1046-1662
ZN;COO;GOL;
Assess
Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme A.monomer1046-1661
ZN;1VU;DMS;GOL;
Assess
Human P300 complexed with a proline-based inhibitormonomer1048-1661
ZN;EDO;C0C;
Assess
Human P300 complexed with a glycine-based inhibitormonomer1048-1661
ZN;EDO;C3I;ACT;
Assess
Crystal structure of the p300 acetyltransferase catalytic core with coenzyme A.monomer1048-1661
ZN;COA;
Assess
Crystal structure of EP300 HAT domain in complex with compound 10monomer1162-1664
ZN;KQO;
Assess
Crystal structure of EP300 HAT domain in complex with compound 7monomer1162-1664
ZN;6TI;
Assess
Crystal structure of EP300 HAT domain in complex with compound 11monomer1162-1664
ZN;6YI;
Assess
Crystal structure of EP300 HAT domain in complex with compound (+)-3monomer1162-1662
ZN;6QI;
Assess
Human P300 complexed with an azaindazole inhibitormonomer1285-1663
ETL;
Assess
Crystal structure of p300 histone acetyltransferase domain in complex with a bisubstrate inhibitor,…monomer1287-1664
BR;01K;
Assess
Crystal structure of p300 histone acetyltransferase domain in complex with Acetyl-Coenzyme Amonomer1287-1664
ACO;DMS;
Assess
Crystal structure of p300 histone acetyltransferase domain in complex with Coenzyme Amonomer1287-1664
PEG;DMS;COA;
Assess
Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor, Acetonyl-C…monomer1287-1664
SOP;DMS;
Assess
Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 1monomer1287-1664
QRY;CL;SO4;
Assess
Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-076 and CoAmonomer1287-1662
COA;OK7;
Assess
Crystal structure of the p300 acetyltransferase domain with peptide-competitive inhibitor 2monomer1287-1662
COA;QS4;DMS;
Assess
The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate r…monomer1287-1661
6TF;NA;
Assess
Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 12monomer1287-1661
QSD;SO4;CL;
Assess
Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-090 and CoAmonomer1287-1661
COA;OJ7;
Assess
Discovery of Spirohydantoins as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acety…monomer1287-1661
Y2P;
Assess
Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 17monomer1288-1661
SO4;CL;QS1;
Assess
Crystal structure of the bromodomain of human EP300 bound to the inhibitor XDM1monomer1046-1161
XDM;SO4;EDO;
Assess
Crystal structure of EP300 bromodomain in complex with SGC-CBP30 chemical probemonomer1048-1161
2LO;IPA;
Assess
Crystal structure of the bromodomain of human Ep300 bound to the inhibitor XDM3dmonomer1048-1161
71Y;ACT;
Assess
Crystal structure of the human bromodomain of EP300 bound to the inhibitor XDM-CBPmonomer1048-1161
99E;EDO;
Assess
Bromodomain of EP300 liganded with BMS-536924monomer1048-1161
N6I;PE5;EDO;
Assess
Crystal Structure of the Bromodomain of Human EP300monomer1047-1160
CL;PEG;
Assess
Bromodomain of EP300 liganded with CCS-1477monomer1049-1160
JHL;EDO;NI;
Assess
Crystal structure of the Taz2 domain of p300monomer1726-1834
ZN;SO4;
Assess
Crystal structure of the Taz2:C/EBPepsilon-TAD chimera proteinmonomer1729-1818
ZN;TCE;TAM;ACN;
Assess
Solution structure of p300Taz2-p73TA1monomer1723-1812
ZN;
Assess
Solution Structure of p300Taz2-p63TAmonomer1723-1812
ZN;
Assess
NMR solution structures of p300 TAZ2 domain in complex with BRD4-NUT F1c domain binding motif #2monomer1723-1812
ZN;
Assess

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1sb0.1.Amonomer0.67566-652
89.66
Assess
6gyr.2.Amonomer0.621046-1664
ZN;99.49
Assess
1p4q.1.Bmonomer0.61323-423
ZN;100.00
Assess
8han.1.Imonomer0.581052-1663
87.16
Assess
8haj.1.Kmonomer0.581050-1664
100.00
Assess